Concert rises after selling CF programs to Vertex

Concert Pharmaceuticals Inc. (NASDAQ:CNCE) jumped $5.99 (62%) to $15.64 on Monday after it said Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Read the full 185 word article

User Sign In